JP5462268B2 - エポチロングリコシド類化合物とそれを活性成分とする配合物及びその応用 - Google Patents
エポチロングリコシド類化合物とそれを活性成分とする配合物及びその応用 Download PDFInfo
- Publication number
- JP5462268B2 JP5462268B2 JP2011529435A JP2011529435A JP5462268B2 JP 5462268 B2 JP5462268 B2 JP 5462268B2 JP 2011529435 A JP2011529435 A JP 2011529435A JP 2011529435 A JP2011529435 A JP 2011529435A JP 5462268 B2 JP5462268 B2 JP 5462268B2
- Authority
- JP
- Japan
- Prior art keywords
- epothilone
- compound
- glycoside
- epothilone glycoside
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Description
菌採取用土壌サンプルは雲南省の程海湖の岸から採取したもので、次の方法によって菌株を分離する。
通常の培養方法によって、固体CNST培地上で、粘液細菌(Sorangium cellulosum ) So0157-2 CCTCC NO:M 208078菌体を選択して、固体M26平板に接種する。それから、30℃の下で、3-4日間培養した後、菌体を掻き取って、50mlの液体M26培地の振盪培養機に接種し、30℃の下で、4-5日間培養して、対数レベルの生長期になると、滅菌ボトル回転機で菌体を均一にミックスし、M26液体培地に接種し換えて、拡大培養を行う。拡大培養が終わると、菌体を固体発酵の種として、無菌水で菌体を洗浄してから、菌体を掻き落として、CNST培地のろ過紙上に均一に塗り、30℃の下で3-4日間培養して、対数レベルの生長期になると、2%の比例によって、ろ過紙上に1層のXAD16樹脂を敷き、30℃の下で、次の代謝段階に完全入るまで、引き続き7-9日間培養する。
上記粘液細菌(Sorangium cellulosum ) So0157-2 CCTCC NO:M 208078の発酵抽出物を中圧の液相カラムクロマトグラフィーで分離(RP-18, 80 g)し、メタノール溶液システムで洗脱する。50%の1500mlから、M1+M2(940mg)が得られ、65% 700 ml (M3, 100 mg) 75% 700 ml (M4, 250 mg)、300mlのメタノール洗浄カラム(M5, 82 mg)、TLC検査、石油エーテル/アセトン(3:2)で展開することによって、流動成分M3とM4の中にはアルカロイド・カラーリージェントによってイングレーンされた斑点が含有されている。しかも、M3の中には一つの極性の比較的大きいアルカロイド・カラーリージェントによってイングレーンされた斑点がある。
ESIMS質量スペクトルの結果によって得られた化合物EPO-Eの準分子イオンピークはm/z 626.4[M + H]+及び648.3 [M + Na]+であるので、化合物の分子量は625である。しかも、裂けたm/z 133の砕片ピークm/z 492がある。高解像度快速原子衝撃質量スペクトルの結果によって、この化合物の分子式はC31H47NO10S (HRFAB-MS、実際測定値:m/z 625.7706、計算値:m/z 625.2921)である。
b 特別な説明がない限り、プロトン信号は1Hに帰一化される。
選別方法:
メチル・チアゾール・テトラゾリウム(methyl-thiazol-tetozolium,MTT)の還元法
スルホードアミンB(sulforhodamine B,SRB)のプロティン染色法
細胞株:HepG2ヒト肝癌、A-549ヒト肺癌及びMDA-MB-435ヒト乳腺癌
作用時間:48〜72h
結果評価:無効:10-5 mol/L < 85%
弱効果:10-5 mol/L ≧ 85%又は10-6 mol/L > 50%
強効果:10-6 mol/L > 85%又は10-7 mol/L > 50%
具体的な実験結果は表2を参照。
Claims (1)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810157514.2 | 2008-10-06 | ||
CNA2008101575142A CN101362784A (zh) | 2008-10-06 | 2008-10-06 | 埃博霉素苷类化合物和以其为活性成分的组合物及其应用 |
PCT/CN2008/001946 WO2010040252A1 (zh) | 2008-10-06 | 2008-11-28 | 埃博霉素苷类化合物和以其为活性成分的组合物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012504559A JP2012504559A (ja) | 2012-02-23 |
JP5462268B2 true JP5462268B2 (ja) | 2014-04-02 |
Family
ID=40389409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011529435A Expired - Fee Related JP5462268B2 (ja) | 2008-10-06 | 2008-11-28 | エポチロングリコシド類化合物とそれを活性成分とする配合物及びその応用 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20100249050A1 (ja) |
EP (1) | EP2332950B1 (ja) |
JP (1) | JP5462268B2 (ja) |
CN (1) | CN101362784A (ja) |
WO (1) | WO2010040252A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014185717A1 (ko) * | 2013-05-15 | 2014-11-20 | 한국생명공학연구원 | 신규한 에포싸일론 유도체 및 그의 용도 |
KR101575295B1 (ko) * | 2014-01-21 | 2015-12-09 | 선문대학교 산학협력단 | 신규한 에포틸론 글리코시드 및 이의 제조방법 |
KR101763344B1 (ko) | 2015-07-06 | 2017-07-31 | 선문대학교 산학협력단 | 신규한 에포틸론 a 유도체 및 이의 용도 |
AU2018298187A1 (en) * | 2017-07-04 | 2020-02-06 | Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | Use of isovalerylspiramycin I, II and/or III in preparation of drug for treating and/or preventing tumour, and drug |
CN111205343B (zh) * | 2020-01-08 | 2022-06-14 | 山东大学 | 埃博霉素b的氮乙酰葡萄糖苷或半乳糖苷化合物及其酶法制备与应用 |
CN111138444B (zh) * | 2020-01-08 | 2022-05-03 | 山东大学 | 一组埃博霉素b葡萄糖苷类化合物及其酶法制备与应用 |
EP4062913B1 (en) * | 2020-09-02 | 2024-05-08 | Beijing Biostar Pharmaceuticals Co., Ltd. | Solid oral formulation of utidelone |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4138042C2 (de) * | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel |
ATE267197T1 (de) * | 1996-11-18 | 2004-06-15 | Biotechnolog Forschung Gmbh | Epothilon d, dessen herstellung und dessen verwendung als cytostatisches mittel bzw. als pflanzenschutzmittel |
WO2002080846A2 (en) * | 2001-04-03 | 2002-10-17 | Kosan Biosciences, Inc. | Epothilone derivatives and methods for making and using the same |
CN101177425B (zh) * | 2003-01-28 | 2012-07-18 | 北京华昊中天生物技术有限公司 | 一类新型埃坡霉素化合物及其制备方法和用途 |
US7893268B2 (en) * | 2005-07-27 | 2011-02-22 | University Of Toledo | Epithiolone analogues |
-
2008
- 2008-10-06 CN CNA2008101575142A patent/CN101362784A/zh active Pending
- 2008-11-28 JP JP2011529435A patent/JP5462268B2/ja not_active Expired - Fee Related
- 2008-11-28 WO PCT/CN2008/001946 patent/WO2010040252A1/zh active Application Filing
- 2008-11-28 EP EP08877222.3A patent/EP2332950B1/en not_active Not-in-force
-
2010
- 2010-06-09 US US12/796,700 patent/US20100249050A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2012504559A (ja) | 2012-02-23 |
EP2332950A1 (en) | 2011-06-15 |
US20100249050A1 (en) | 2010-09-30 |
CN101362784A (zh) | 2009-02-11 |
EP2332950A4 (en) | 2014-03-12 |
WO2010040252A1 (zh) | 2010-04-15 |
EP2332950B1 (en) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5462268B2 (ja) | エポチロングリコシド類化合物とそれを活性成分とする配合物及びその応用 | |
JP5866737B2 (ja) | レボロキタマイシン、その薬物組成物、調製方法及び応用 | |
CN107353274B (zh) | 源于草酸青霉的黑麦酮酸i及制备抗人食管癌药物的应用 | |
WO2011085523A1 (zh) | 18元或14元大环内酯类埃博霉素化合物及其应用 | |
JPS60115599A (ja) | Bbm―2478a抗生物質 | |
CN103665071A (zh) | 洋橄榄叶素衍生物及其在抗耐药菌和耐药结核分枝杆菌感染中的应用 | |
CN113402509B (zh) | 一组美沙达唑类化合物及其制备方法和应用 | |
CN107298669B (zh) | 源于草酸青霉的黑麦酮酸i及抗人口腔表皮样癌药物应用 | |
CN101948472B (zh) | 一类十字孢碱类似物及其制备方法和用途 | |
CZ279307B6 (cs) | Rebeccamycinový analog, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje | |
CN110330544A (zh) | 一种4,4,1-双环甾类化合物及其制备方法和用途 | |
JPH0232092A (ja) | 抗生物質bu―3608dおよびbu―3608e | |
CN109134416B (zh) | 源于草酸青霉的黑麦酮酸h在制备人子宫颈癌药物的应用 | |
CN114149445B (zh) | 一种氧杂蒽酮类化合物的制备方法及其在抗耐药细菌方面的应用 | |
CN115806881A (zh) | 一种青霉属真菌及其在制备抗菌药物中的应用 | |
WO2000042062A1 (fr) | Nouveau compose a base de depsipeptide | |
CN115109023A (zh) | 大环内酯类化合物fwyz52-a、其发酵菌株、发酵方法及应用 | |
CN108102933A (zh) | 一株白黄黑链霉菌菌株及其应用 | |
WO2007007399A1 (ja) | チアゾール系化合物 | |
JP5461082B2 (ja) | ストレプトミセス属に属する新規微生物、その微生物が産生する新規化合物、及びその化合物を有効成分とする医薬 | |
CN109134417B (zh) | 源于草酸青霉的黑麦酮酸i及抗人子宫颈癌药物的应用 | |
CN112961170B (zh) | 一株海绵来源放线菌及所产含硫生物碱的制备方法和应用 | |
CN111588717A (zh) | 两个四重内酯类抗生素作为抗mrsa药物的应用及其提取分离方法 | |
CN107513072B (zh) | 聚酮在抑制hiv中的应用 | |
CN110327328A (zh) | 25β-仲丁烯基-23β-异丁酰氧基米尔贝霉素衍生物在抗肿瘤中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130712 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131011 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131021 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131105 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131203 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131203 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131225 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140116 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |